Sonia Hernandez-Diaz, MD, MPH, FISPE

Professor of Epidemiology
Harvard School of Public Health
Boston, Massachusetts, United States

Sonia Hernandez-Diaz, MD, DrPH is a Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Her area of interest is drug safety evaluation from non-randomized data, with a special emphasis on the design, conduct, and analysis of studies in pregnant women and their infants. She is Past-President of the International Society for Pharmacoepidemiology and the Society for Perinatal and Pediatric Epidemiology Research; and serves as a Special Government Employee for the FDA Drug Safety and Risk Management Advisory Committee (current Chair), as a member of the NICHD Pregnancy & Neonatology (PN) Study Section, and as member of the Teratogenic Information Services (TERIS) Advisory Board.

Roche (Consultant/Advisory Board)Takeda (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)UCB (Consultant/Advisory Board)

Presentation(s):

• Modern Pregnancy Pharmacoepidemiology: Emulating Target Trials

  Thursday, August 25, 2022
  8:30 AM – 12:30 PM CEST

• Post-authorization Regulatory Strategies to Evaluate Drug Safety in Pregnancy: How to Optimize the Design of Registries & Database Studies

  Friday, August 26, 2022
  10:30 AM – 12:00 PM CEST

• Psychostimulant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

  Friday, August 26, 2022
  2:00 PM – 2:15 PM CEST

• Topiramate During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Initiation of Atenolol versus Methyldopa During Pregnancy and the Risk of Intrauterine Growth Restriction/small for Gestational Age

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Emulating a Sequence of Target Trials to Avoid Immortal Time Bias in Pregnancy Studies — an Application to Antibiotic Initiation and Preterm Delivery

  Saturday, August 27, 2022
  8:45 AM – 9:00 AM CEST

• Female Preconception Vaccination Against COVID-19 And Spontaneous Abortion in A Prospective Preconception Cohort Study

  Saturday, August 27, 2022
  5:15 PM – 5:30 PM CEST

• Development and Validation of Claims-based Algorithms for Estimating Gestational Age of Spontaneous Abortion and Termination

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST

• Hierarchical Clustering Analysis to Inform Classification of Congenital Malformations for Surveillance of Medication Safety in Pregnancy

  Sunday, August 28, 2022
  9:15 AM – 9:30 AM CEST

• mRNA COVID-19 Vaccination Early in Pregnancy and Risk of Spontaneous Abortion in an International Pregnancy Registry

  Sunday, August 28, 2022
  2:45 PM – 3:00 PM CEST